Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa, Dystrophic”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Early research (Phase 1)Study completedNCT02493816
What this trial is testing

Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
King's College London 5
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Not applicableEnrolling By InvitationNCT05708677
What this trial is testing

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Who this might be right for
RDEB
Abeona Therapeutics, Inc 22
Not applicableLooking for participantsNCT06563414
What this trial is testing

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica Dominans
Krystal Biotech, Inc. 40
Not applicableStudy completedNCT03183934
What this trial is testing

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 2
Very early researchStudy completedNCT04177498
What this trial is testing

Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Thomas Jefferson University 3
Testing effectiveness (Phase 2)Looking for participantsNCT05157958
What this trial is testing

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 6
Not applicableWithdrawnNCT02004600
What this trial is testing

Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB

Who this might be right for
Dystrophic Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice
Very early researchStudy completedNCT05533866
What this trial is testing

Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution

Who this might be right for
Epidermolysis Bullosa
Northwestern University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06594393
What this trial is testing

TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Who this might be right for
Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa
Xinnate AB 32
Testing effectiveness (Phase 2)Study completedNCT03786237
What this trial is testing

Rigosertib for RDEB-SCC

Who this might be right for
Epidermolysis Bullosa DystrophicaSquamous Cell Carcinoma
Prof. Johann Bauer 2
Not applicableUnknownNCT04285294
What this trial is testing

Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)Looking for participantsNCT07193134
What this trial is testing

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Who this might be right for
RDEBRecessive Dystrophic Epidermolysis BullosaEpidermolysis Bullosa Dystrophica, Recessive
CHU de Quebec-Universite Laval 9
Not applicableStudy completedNCT00904163
What this trial is testing

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 13
Early research (Phase 1)Study completedNCT03472287
What this trial is testing

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more
Castle Creek Pharmaceuticals, LLC 11
Not applicableStudy completedNCT04757727
What this trial is testing

Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)

Who this might be right for
Dystrophic Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice 27
Not applicableUnknownNCT05033574
What this trial is testing

The State of Sexual Development in Children With Inherited Epidermolysis Bullosa

Who this might be right for
Dermatologic DiseaseEpidermolysis BullosaEpidermolysis Bullosa Simplex+5 more
National Medical Research Center for Children's Health, Russian Federation 50
Not applicableLooking for participantsNCT06423573
What this trial is testing

Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

Who this might be right for
Epidermolysis Bullosa, DystrophicEpidermolysis Bullosa, Junctional
Amryt Pharma 580
Testing effectiveness (Phase 2)Study completedNCT01538862
What this trial is testing

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Vanderbilt University Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT00951964
What this trial is testing

Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)

Who this might be right for
Epidermolysis Bullosa Dystrophica
Centre Hospitalier Universitaire de Nice 18
Load More Results